CYABRA, INC.

CIK: 2032341 Filed: June 12, 2026 8-K Financial Distress High Impact

Key Highlights

  • AI-driven technology platform specializing in fake account and bot detection
  • Active grace period until December 7, 2026, to regain Nasdaq compliance
  • Operational focus on business growth to drive organic stock price recovery

Event Analysis

CYABRA, INC. Update: Nasdaq Listing Status

If you follow Cyabra, Inc. (ticker: CYAB), you may have seen news about their status on the Nasdaq. Cyabra uses AI to spot fake accounts and bots on social media. I have broken down what this regulatory notice means so you can skip the legal jargon.

1. What happened?

On June 9, 2026, the Nasdaq Stock Market LLC notified Cyabra that it is "out of compliance" with two rules required to stay on the Nasdaq Capital Market.

In plain English: To stay on the Nasdaq, companies must meet specific financial standards. Cyabra missed the mark in two areas:

  • Market Value of Publicly Held Shares: The total value of their shares held by the public dropped below the $15 million requirement.
  • Minimum Bid Price: Their stock price traded below $1.00 per share for 30 business days in a row.

2. Are they being kicked off the exchange?

Not yet. This notice is a warning, not an immediate removal. Cyabra’s stock will continue to trade as usual under the symbol "CYAB." The company has a "grace period" to meet these standards again.

3. What is the timeline?

Cyabra has 180 calendar days—until December 7, 2026—to fix these issues.

  • To fix the share price: The stock must close at or above $1.00 per share for at least 10 business days in a row before the deadline.
  • To fix the market value: The total value of publicly held shares must reach at least $15 million for at least 10 business days in a row before the deadline.

4. Why does this matter?

A Nasdaq listing offers prestige, oversight, and easy trading. If Cyabra fails to meet these rules by the deadline, they could be removed from the exchange. This would move the stock to "Over-the-Counter" (OTC) markets. OTC markets generally have fewer reporting requirements, lower trading volume, and higher price swings. This move can make it harder for large institutions to hold the stock and may hurt the company’s reputation and ability to raise money.

5. What should investors know?

  • Market Signal: This notice shows the company is struggling to meet Nasdaq’s minimum valuation standards.
  • Performance Pressure: The company is now in a "wait and see" period. Investors will look for business growth or new strategies that could naturally push the stock price and market value back above the required levels.
  • Company Strategy: The company is monitoring its share price and market value and is considering options to regain compliance, such as business growth or corporate actions. They didn't provide specific details on which path they will take, so investors should watch for official company announcements in the coming months.
  • Risk Disclosure: The company stated there is "no assurance" they will regain compliance. There is a real risk the stock could be removed if they fail to meet the requirements or secure an extension.

6. How to approach this

When a company receives a deficiency notice, it’s a signal to pay closer attention to their quarterly earnings and press releases. If you are holding or considering buying CYAB, keep an eye on whether they can generate positive momentum in their business operations. If the stock price doesn't recover naturally through growth, companies sometimes resort to "reverse stock splits" to artificially boost the share price—a move that doesn't change the company's value but can impact how the stock is perceived.


Disclaimer: I am here to explain the news. I am not a financial advisor, and this is not investment advice. Always do your own research before making any decisions with your money.

Key Takeaways

  • The Nasdaq notice is a warning, not an immediate delisting; trading continues as normal.
  • The company must achieve $1.00/share and $15M market value for 10 consecutive days by Dec 7, 2026.
  • Investors should monitor quarterly earnings for growth signals that could naturally restore valuation.
  • Be aware of the possibility of a reverse stock split as a potential, albeit artificial, compliance strategy.

Why This Matters

This event represents a critical inflection point for Cyabra, signaling that the company’s current market valuation is failing to meet the rigorous institutional standards required for a major exchange listing. For retail investors, this serves as a high-stakes 'performance audit.' The company is now under immense pressure to prove that its AI-driven business model can generate the rapid growth or capital infusion necessary to maintain its premium listing. We highlight this because it initiates a 180-day countdown—a period where volatility often spikes as the market reacts to the company’s attempts to regain compliance. Whether Cyabra achieves this through organic revenue growth, a reverse stock split, or a strategic corporate restructuring will dictate the stock's future accessibility to institutional capital and its long-term viability. This situation is not unique in the current market environment. We have observed similar patterns across various sectors, such as the recent struggles of **Ensysce Biosciences, Inc.**, which faced a $2.5 million stockholders' equity threshold, and **Curanex Pharmaceuticals Inc**, which grappled with the $1.00 minimum share price requirement. Much like **Smart Powerr Corp.**, which also faced scrutiny over its sub-$1.00 trading price, Cyabra must now navigate a narrow path to avoid the potential for delisting. Investors should look to the outcomes of companies like **Nuburu, Inc.**, which recently engaged in active financial restructuring to address capital shortages, as a blueprint for how these situations can evolve. Ultimately, the next six months will be a test of management’s ability to stabilize the balance sheet and restore investor confidence before the exchange’s patience runs out.

Financial Impact

Company is currently out of compliance with Nasdaq listing standards, risking potential delisting to OTC markets which could limit institutional investment and capital raising ability.

Affected Stakeholders

Investors
Regulators

About This Analysis

AI-powered summary derived from the original SEC filing.

Document Information

Event Date: June 9, 2026
Processed: June 13, 2026 at 02:54 AM

AI-Generated Analysis

This analysis is AI-generated from SEC filings. This is educational content, not financial advice. Always consult a financial advisor before making investment decisions.

Back to All Events